• 제목/요약/키워드: HORMONE

검색결과 3,860건 처리시간 0.038초

Molecular study of Insulin-Like Growth Factor-I in goat

  • Chang, Hyo-Young;Chung, Su-Wol;Han, Yong-Mahn;Lee, Kyung-Kwang;Lee, Jong-Bin;Blaise Lee, Hwang-Hee
    • 한국동물학회:학술대회논문집
    • /
    • 한국동물학회 1996년도 한국생물과학협회 국제학술대회
    • /
    • pp.172.1-172
    • /
    • 1996

  • No Abstract, See Full Text

  • PDF

Mechanism of Growth Hormone Action : Recent Developments - A Review

  • Sodhi, R.;Rajput, Y.S.
    • Asian-Australasian Journal of Animal Sciences
    • /
    • 제14권12호
    • /
    • pp.1785-1793
    • /
    • 2001

  • The interaction of growth hormone with it's receptor results in dimerization of receptor, a feature known in action of certain cytokines. The interaction results in generation of number of signalling molecules. The involvement of Janus kinases, mitogen activated kinases, signal transduction and activator of transcription proteins, insulin like substrate, phosphatidylinositol 3-kinase, phospholipase C, protein kinase C is almost established in growth hormone action. There are still many missing links in explaining diversified activities of growth hormone. Amino acid sequence data for growth hormones and growth hormone receptors from a number of species have proved useful in understanding species specific effects of growth hormone. Complete understanding of growth hormone action can have implications in designing drugs for obtaining desired effects of growth hormone.

  • https://doi.org/10.5713/ajas.2001.1785 인용 PDF

Resistance to Thyroid Hormone Syndrome Mutation in THRB and THRA: A Review

  • Jung Eun Moon
    • Journal of Interdisciplinary Genomics
    • /
    • 제5권2호
    • /
    • pp.32-34
    • /
    • 2023

  • Resistance to thyroid hormone syndrome (RTH) is a genetic disease caused by the mutation of either the thyroid hormone receptor-β (THRB) gene or the thyroid hormone receptor-α (THRA) gene. RTH caused by THRB mutations (RTH-β) is characterized by the target tissue's response to thyroid hormone, high levels of triiodothyronine and/or thyroxine, and inappropriate secretion of thyroid-stimulating hormone (TSH). THRA mutation is characterized by hypothyroidism that affects gastrointestinal, neurological, skeletal, and myocardial functions. Most patients do not require treatment, and some patients may benefit from medication therapy. These syndromes are characterized by decreased tissue sensitivity to thyroid hormones, generating various clinical manifestations. Thus, clinical changes of resistance to thyroid hormones must be recognized and differentiated, and an approach to the practice of personalized medicine through an interdisciplinary approach is needed.

  • https://doi.org/10.22742/JIG.2023.5.2.32 인용 PDF